This is a very important milestone, especially for those hoping for a TO in the near future.
These Phase 2 trials greatly strengthen our 'neuro weapons bank', making us a far more desirable target
and therefore one that will have greater bargaining power (in a possible TO).
Of course, the current 'strange' and low share price is not ideal, so hopefully this may give it some support.
Ann: Positive FDA meetings enable INDs for three Phase 2 trials, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.96 |
Change
-0.140(1.07%) |
Mkt cap ! $1.612B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.36 | $12.82 | $4.627M | 354.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7585 | $12.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.03 | 3344 | 2 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |